Kitai Y, et al. Onco-nephrology: current concepts and future perspectives. Jpn J Clin Oncol. 2015;45:617–28.

Article  PubMed  Google Scholar 

Hilberg F, Roth GJ, Krssak M, Kautschitsch S, Sommergruber W, Tontsch-Grunt U, et al. Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res. 2008;68:4774–82.

Article  CAS  PubMed  Google Scholar 

Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071–82.

Article  PubMed  Google Scholar 

Ismail I, Nigam S, Parnham A, Srinivasa V. Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report. J Med Case Rep. 2017;11:214.

Article  PubMed  PubMed Central  Google Scholar 

Estrada CC, Maldonado A, Mallipattu SK. Therapeutic inhibition of VEGF signaling and associated nephrotoxicities. JASN. 2019;30(2):187–200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gordon MS, Cunningham D. Managing patients treated with bevacizumab combination therapy. Oncology. 2005;69:25–33.

Article  CAS  PubMed  Google Scholar 

Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med. 2003;349:427–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Izzedine H, Massard C, Spano JP, Goldwasser F, Khayat D, Soria JC. VEGF signalling inhibition-induced proteinuria: mechanisms, significance and management. Eur J Cancer. 2010;46:439–48.

Article  CAS  PubMed  Google Scholar 

Eremina V, Jefferson JA, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358(11):1129–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Izzedine H, Mangier M, Ory V, Zhang SY, Sendeyo K, Bouachi K, et al. Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy. Kidney Int. 2014;85:457–70.

Article  CAS  PubMed  Google Scholar 

Zhang SY, Kamal M, et al. c-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal. 2010;3(122):ra39–ra39.

Article  PubMed  PubMed Central  Google Scholar 

Tota M, Baron V, Musial K, et al. Secondary IgA nephropathy and IgA-associated nephropathy: a systematic review of case reports. J Clin Med. 2023;12:2726.

Article  PubMed  PubMed Central  Google Scholar 

Tanabe K, et al. Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: a case report. Medicine (Baltimore). 2020;99(21):e20464.

Article  PubMed  PubMed Central  Google Scholar 

Hasegawa M, Uehara A, Suzuki T, Sekine R, Yazawa M, Ichikawa D, et al. Nintedanib-induced glomerular microangiopathy: a case report. CEN Case Rep. 2020;9:295–300.

Article  PubMed  PubMed Central  Google Scholar 

Inoue D, Nishi H, Honda K, Ishii T, Abe H, Sato M, et al. Renal thrombotic microangiopathy during nintedanib treatment for idiopathic pulmonary fibrosis. Clin Nephrol. 2020;93:47–50.

Article  PubMed  Google Scholar 

Fujita T, Nakagawa H, Yokota T, Umetani J, Nagawa D, Nakata M, et al. Nintedanib-induced renal thrombotic microangiopathy. Case Rep Nephrol Dial. 2021;11:227–32.

Article  PubMed  PubMed Central  Google Scholar 

Sofue T, Oguchi H, Yazawa M, et al. Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: a multicenter prospective observational study. PLoS ONE. 2023;18:e0281945.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bayer G, Von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, et al. Etiology and outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol. 2019;14:557–66.

Article  PubMed  PubMed Central  Google Scholar 

Mazzierli T, Allegretta F, Maffini E, Allinovi M. Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management. Front Pharmacol. 2023;13:1088031.

Article  PubMed  PubMed Central  Google Scholar 

Cécile V, Nolwenn L, et al. All anti-vascular endothelial growth factor drugs can induce ‘pre-eclampsia-like syndrome’: a RARe study. Nephrol Dial Transplant. 2014;29(2):325–32.

Article  Google Scholar 

Mihatsch MJ, Morozumi K, Strøm EH, Ryffel B, Gudat F, Thiel G. Renal transplant morphology after long-term therapy with cyclosporine. Transplant Proc. 1995;27(1):39–42.

CAS  PubMed  Google Scholar 

Kusano T, Takano H, Kang D, Nagahama K, Aoki M, Morita M, et al. Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy. Hum Pathol. 2016;49:135–44.

Article  CAS  PubMed  Google Scholar 

Hatanaka S, Kanzaki G, Koike K, Ueda H, Matsuo N, Maruyama Y, et al. Effective combination of corticosteroid and cyclosporine A for immunoglobulin A nephropathy with membranoproliferative glomerulonephritis features: a case report. CEN Case Rep. 2025;14(3):486–92.

Article  PubMed  Google Scholar 

Andeen NK, Jefferson JA, Akilesh S, Alpers CE, Bissonnette ML, Finn LS, et al. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury. Hum Pathol. 2018;81:272–80.

Article  PubMed  Google Scholar